Skip to main content

Full text of "USPTO Patents Application 10585695"

See other formats


ticwiiuiiiw nwivi luvvicu^ciiiciiL ncwcipi 


EFSID: 


4546744 


Application Number: 


10585695 


International Application Number: 




Confirmation Number: 


4082 


Title of Invention: 


Compounds, Pharmaceutical Compositions and Therapeutic Methods of 
Preventing and Treating Diseases and Disorders Associated With Amyloid 
Fibril Formation 


First Named Inventor/Applicant Name: 


Hermona Soreq 


Customer Number: 


67801 


Filer: 


Martin Dennis Moynihan/Kitty Huffman 


Filer Authorized By: 


Martin Dennis Moynihan 


Attorney Docket Number: 


30394 


Receipt Date: 


01-JAN-2009 


Filing Date: 




Time Stamp: 


21:49:41 


Application Type: 


U.S. National Stage under 35 USC 371 



Payment information: 



Submitted with Payment 


no 








File Listing: 


Document 
Number 


Document Description 


File Name 


FileSize(Bytes)/ 
Message Digest 


Multi 
Part /.zip 


Pages 
(ifappl.) 


1 


Information Disclosure Statement Letter 


USPTOIetter.pdf 


36235 




1 


Warnings: 












Information: 



2 


Information Disclosure Statement (IDS) 
Filed (SB/08) 


Form1449.pdf 


97988 




2 




Warnings: 


Information: 


This is not an USPTO supplied IDS tillable form 


3 


NPL Documents 


01.pdf 


86347 




2 


d6948d357c3ed3c85d138d1c6381cc800d 


Warnings: 


Information: 


4 


NPL Documents 


02.pdf 


65432 




2 


8ca21 db97746e8d a 373c84baa21 0c83244 


Warnings: 


Information: 


5 


NPL Documents 


03.pdf 


140690 




4 


IblScI 


Warnings: 


Information: 


6 


NPL Documents 


04.pdf 


198309 


no 


5 




Warnings: 


Information: 


7 


NPL Documents 


05.pdf 


364267 


no 


8 


0eb8c5c09e10f39ab017bdde6a0346002b3 


Warnings: 


Information: 


8 


NPL Documents 


06.pdf 


70810 




3 


a 856369607d26706ed2bb406be93af7b8cd 


Warnings: 


Information: 


9 


NPL Documents 


07.pdf 


152451 


no 


5 


0cbc6af614be2708f5e15d4d2d834409e20 


Warnings: 


Information: 


10 


NPL Documents 


08.pdf 


100349 




4 





Warnings: 


Information: 


11 


NPL Documents 


09.pdf 






11 


Warnings: 












Information: 


12 


NPL Documents 


10.pdf 


1 1 00207 




5 


Warnings: 












Information: 


13 


NPL Documents 


11.pdf 


527994 




8 


Warnings: 












Information: 






Total Files Size (in bytes] 


3425933 





This Acknowledgement Receipt evidences receipt on the noted date by the USPTO of the indicated documents, 
characterized by the applicant, and including page counts, where applicable. It serves as evidence of receipt similar to a 
Post Card, as described in MPEP 503. 



New Applications Under 35 U.S.C. 1 1 1 

If a new application is being filed and the application includes the necessary components for a filing date (see 37 CFR 
1 .53(b)-(d) and MPEP 506), a Filing Receipt (37 CFR 1.54) will be issued in due course and the date shown on this 
Acknowledgement Receipt will establish the filing date of the application. 

National Stage of an International Application under 35 U.S.C. 371 

If a timely submission to enter the national stage of an international application is compliant with the conditions of 35 
U.S.C. 371 and other applicable requirements a Form PCT/DO/EO/903 indicating acceptance of the application as a 
national stage submission under 35 U.S.C. 371 will be issued in addition to the Filing Receipt, in due course. 

New International Application Filed with the USPTO as a Receiving Office 

If a new international application is being filed and the international application includes the necessary components for 
an international filing date (see PCT Article 1 1 and MPEP 1 81 0), a Notification of the International Application Number 
and of the International Filing Date (Form PCT/RO/105) will be issued in due course, subject to prescriptions concerning 
national security, and the date shown on this Acknowledgement Receipt will establish the international filing date of 
the application.